about
Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma.Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event DataClinical significance of signs of autoimmune colitis in 18F-fluorodeoxyglucose positron emission tomography-computed tomography of 100 stage-IV melanoma patientsThe outcome of ex vivo TIL expansion is highly influenced by spatial heterogeneity of the tumor T-cell repertoire and differences in intrinsic in vitro growth capacity between T-cell clonesPredominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma
P50
description
researcher
@en
wetenschapper
@nl
name
Jessica C Hassel
@en
Jessica C Hassel
@nl
type
label
Jessica C Hassel
@en
Jessica C Hassel
@nl
prefLabel
Jessica C Hassel
@en
Jessica C Hassel
@nl
P31
P496
0000-0001-7575-6230